awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38210475-58CCBF6B-A4E3-460F-BE17-A2E0B11B135C
Q38210475-58CCBF6B-A4E3-460F-BE17-A2E0B11B135C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38210475-58CCBF6B-A4E3-460F-BE17-A2E0B11B135C
Current and potential epigenetic targets in multiple myeloma.
P2860
Q38210475-58CCBF6B-A4E3-460F-BE17-A2E0B11B135C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38210475-58CCBF6B-A4E3-460F-BE17-A2E0B11B135C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a5f66251ccea48222720865adc0f6788a37b33db
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.